Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|September 18, 2004
Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malariaAmbrose O Talisuna, Anne Nalunkuma-Kazibwe, Peter Langi, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 7, 2019
Plasmodium malariae and Plasmodium ovale infections and their association with common red blood cell polymorphisms in a highly endemic area of UgandaLorenzo Subissi, Bernard N Kanoi, Betty Balikagala, et al.
Molecular and Biochemical Parasitology|December 17, 2009
var gene transcription dynamics in Plasmodium falciparum patient isolatesKarin Blomqvist, Johan Normark, Daniel Nilsson, et al.
International Journal for Parasitology|September 18, 2003
Intensity of transmission and spread of gene mutations linked to chloroquine and sulphadoxine-pyrimethamine resistance in falciparum malariaAmbrose O Talisuna, Peter Langi, Theonest K Mutabingwa, et al.
Tropical Medicine & International Health : TM & IH|March 26, 2004
Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan childrenAmbrose O Talisuna, Anne Nalunkuma-Kazibwe, Nathan Bakyaita, et al.
Frontiers in Immunology|June 27, 2022
Meta-Analysis of Human Antibodies Against Plasmodium falciparum Variable Surface and Merozoite Stage AntigensEizo Takashima, Bernard N Kanoi, Hikaru Nagaoka, et al.
Plos Pathogens|October 3, 2006
Release of sequestered malaria parasites upon injection of a glycosaminoglycanAnna M Vogt, Fredrik Pettersson, Kirsten Moll, et al.
Tropical Medicine and Infectious Disease|January 24, 2025
Safety and Efficacy of Incorporating Actellic® 300 CS into Soil Wall Plaster for Control of Malaria Vectors in Rural Northeastern UgandaTonny Jimmy Owalla, Emmanuel Okurut, Kenneth Ssaka, et al.
Frontiers in Immunology|December 12, 2019
The N-Terminal Region of Plasmodium falciparum MSP10 Is a Target of Protective Antibodies in Malaria and Is Important for PfGAMA/PfMSP10 InteractionHikaru Nagaoka, Bernard N Kanoi, Kana Jinoka, et al.
Frontiers in Immunology|October 7, 2022
Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trialsTonny J Owalla, Dianna E B Hergott, Annette M Seilie, et al.
Pageof 5